Sectra ABCHIX:SECTBS 98 Return-on-Tangible-Asset is 16.04% as of Apr. 2026, which is 8% below its 10-year median of 17.44. GuruFocus rates CHIX:SECTBS with a GF Score™ of 98/100 and a GF Value™ of kr308.77 (Modestly Undervalued). Among 855 Medical Devices & Instruments companies, Sectra AB ranks better than 92.28% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Sectra AB's annualizedNet Income for the quarter that ended in Apr. 2026 was kr630 Mil. Sectra AB's average total tangible assets for the quarter that ended in Apr. 2026 was kr3,927 Mil. Therefore, Sectra AB's annualized Return-on-Tangible-Asset for the quarter that ended in Apr. 2026 was 16.04%.
The historical rank and industry rank for Sectra AB's Return-on-Tangible-Asset or its related term are showing as below:
CHIX:SECTBs'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: 14.85 Med: 17.44 Max: 19.94
Current: 15.68
During the past 13 years, Sectra AB's highest Return-on-Tangible-Asset was 19.94%. The lowest was 14.85%. And the median was 17.44%.
CHIX:SECTBs's Return-on-Tangible-Asset is ranked better than 92.28% of 855
companies
in the Medical Devices & Instruments industry
Industry Median: 0.62
vs CHIX:SECTBs: 15.68
Sectra AB (CHIX:SECTBs) Return-on-Tangible-Asset Explanation
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Sectra AB Return-on-Tangible-Asset Related Terms
Sectra AB Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for Sectra AB's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CHIX:SECTBS vs ABT, SYK, MDT: Return-on-Tangible-Asset Comparison
For the Medical Devices subindustry, Sectra AB's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sectra AB Return-on-Tangible-Asset vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Sectra AB's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Sectra AB's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Apr. 2026) net income data.
What does a Return-on-Tangible-Asset of 16.04% mean?
Sectra AB (CHIX:SECTBS) has a Return-on-Tangible-Asset of 16.04% as of Apr. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Sectra AB and its competitors. This is near median its historical median of 17.44. Over the past decade, Sectra AB's Return-on-Tangible-Asset has ranged from 14.85 to 19.94. According to the industry distribution chart, Sectra AB ranks #66 out of 855 companies in the Medical Devices & Instruments industry, placing it in the top 7.7%.
Is Sectra AB's Return-on-Tangible-Asset too high?
Sectra AB's current Return-on-Tangible-Asset of 16.04% is near median its 10-year median of 17.44. Over the past 10 years, this metric has ranged from a low of 14.85 to a high of 19.94. The Medical Devices & Instruments industry median Return-on-Tangible-Asset is 0.62. Sectra AB's value of 16.04% is 2487.1% above this industry median. Based on the distribution chart, Sectra AB ranks #66 out of 855 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Sectra AB has a GF Score™ of 98/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sectra AB's Return-on-Tangible-Asset compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Sectra AB ranks #66 out of 855 companies for Return-on-Tangible-Asset. This places Sectra AB in the top 8% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Asset is 0.62. Sectra AB's value of 16.04% is 2487.1% above this benchmark. Historically, Sectra AB's own Return-on-Tangible-Asset has ranged from 14.85 to 19.94 over the past decade. While the company's 10-year median is 17.44 vs. the industry median of 0.62, Sectra AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Medical Devices & Instruments company?
The median Return-on-Tangible-Asset among Medical Devices & Instruments companies is 0.62, based on 855 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sectra AB's current Return-on-Tangible-Asset of 16.04% is 2487.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Sectra AB and its competitors. For the Medical Devices & Instruments industry, the median Return-on-Tangible-Asset is 0.62 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sectra AB's current Return-on-Tangible-Asset is 16.04%, which is near median its own 10-year median of 17.44. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sectra AB stock overvalued right now?
Based on GuruFocus' analysis, Sectra AB (CHIX:SECTBS) is currently considered Modestly Undervalued. The stock's GF Value™ is kr308.77, compared to a current price of kr277.30 — trading 10.2% below its estimated fair value. The current Return-on-Tangible-Asset is 16.04%, which is near median its 10-year median of 17.44 and 2487.1% above the Medical Devices & Instruments industry median of 0.62. Sectra AB's overall GF Score™ is 98/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Sectra AB (CHIX:SECTBS), the current Return-on-Tangible-Asset is 16.04% as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sectra AB (CHIX:SECTBS) Overvalued in 2026?
Based on GuruFocus' analysis, Sectra AB stock appears to be undervalued.
The current stock price of kr277.30 is trading 10.2% below its estimated GF Value™ of kr308.77.
GuruFocus considers Sectra AB to be Modestly Undervalued.
Key valuation signals for CHIX:SECTBS:
Return-on-Tangible-Asset: 16.04% (near median its 10-year median of 17.44)
GF Value™: kr308.77 vs. price of kr277.30 (10.2% below fair value)
Industry Position: 2487.1% above the Medical Devices & Instruments median (#66 of 855)
No single metric tells the full story. See the CHIX:SECTBS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sectra AB develops IT solutions and services for storing, viewing, and working with medical images. The operating business segments are Imaging IT Solutions, Secure Communications, Business Innovation, and Other Operations. It generates maximum revenue from the Imaging IT Solutions segment. The company also offers maintenance in the form of support, system monitoring, and consulting services related to integration, system design, data migration, and business development. Geographically, it derives a majority of its revenue from the United States, followed by Sweden, the United Kingdom, the Netherlands, the Rest of Europe, and the Rest of the world.
98GF Score
Get the complete analysis for CHIX:SECTBS
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:SECTBS has been successfully added to your 
